MedPath
NMPA Approval

参苓白术散

国药准字Z62020693

August 9, 2024

Drug Information

参苓白术散

武都

散剂

中药

August 9, 2024

Company Information

Applicant Company

甘肃武都工业园区1号

Manufacturing Company

甘肃武都工业园区1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

参苓白术散 - NMPA 批准文号 | MedPath